发明名称 CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
摘要 Provided are methods of suppressing complement alternative pathway in a mammalian subject in need thereof, comprising administering to said subject a therapeutically effective amount of C1q and tumor necrosis factor related protein 6 (CTRP6) or a functional analog thereof.
申请公布号 US9175054(B2) 申请公布日期 2015.11.03
申请号 US201214116039 申请日期 2012.05.09
申请人 The University of Tokyo 发明人 Iwakura Yoichiro;Murayama Masanori;Ishigame Harumichi;Kakuta Shigeru
分类号 A61K38/00;C07K14/47;A61P37/02;A61K38/17;C07K14/575 主分类号 A61K38/00
代理机构 Troutman Sanders LLP 代理人 Sullivan Clark G.;Troutman Sanders LLP
主权项 1. A method of suppressing complement alternative pathway in a mammalian subject in need thereof, comprising administering to the subject a therapeutically effective amount of C1 q and tumor necrosis factor related protein 6 (CTRP6) or a functional analog thereof, wherein the CTRP6 or functional analog comprises the amino acid sequence selected from the group consisting of: a) human CTRP6 (SEQ ID NO: 1); and b) the amino acid sequence having at least 95% sequence identity with C1 q domain of human CTRP6 and activity to suppress complement activation.
地址 Tokyo JP